Nishant Ranawat, MD
Neurology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 25
- 7 carriers
- Offices
- 2
Offices
2 locations · Neuranimus P C · Physician Affiliate Group of New York PC
Hospitals listed: Ochsner Lafayette General Medical Center · South Brooklyn Health. That is not proof they admit you there this week.
Plans that list them
25 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ranawat’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
25 of 25 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ochsner Lafayette General Medical CenterLafayette, LAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Ochsner Health System, which runs 36 hospitals in 3 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.34 (1.1 to 1.58), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.6 (1.09 to 2.11) · 7,930 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.355, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.117, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.252, Oct 2024 – Sep 2025
- South Brooklyn HealthBrooklyn, NYAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of New York City Health and Hospitals Corporation, which runs 12 hospitalsPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.317, Oct 2024 – Sep 2025
See every measure and the patient survey for Ochsner Lafayette General Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.34 (1.1 to 1.58) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.6 (1.09 to 2.11) · 7,930 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.355 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.117 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.252 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.26 (0.38 to 2.13) · 1,835 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 169.88 (126.89 to 212.86) · 144 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 206 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 123 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.2 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 565 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.6 · 482 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.2 · 587 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.3 · 4,966 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.04 to 0.42) · 9,408 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 9,587 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (1.42 to 4.78) · 3,099 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.42 (1.09 to 3.75) · 1,587 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.7 (1.47 to 3.93) · 3,024 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.34 (6.07 to 14.61) · 1,564 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.55 (2.61 to 8.5) · 1,601 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.78 (0.37 to 3.19) · 437 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.5 · 338 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 1.044 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.4 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.447 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 338 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.5 · 849 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.3 · 233 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.2 · 662 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.2 · 522 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 664 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.7 to 6.9) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.3 (9 to 14) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 315 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.1 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 253 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (10.8 to 18.8) · 334 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 751 cases | No different | Jan 2024 – Dec 2024 |
What patients said (822 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 70% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for South Brooklyn Health
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 3 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.91 (0 to 1.92) · 881 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.71 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 157.8 (101.02 to 214.58) · 34 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 179 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 157 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 450 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 698 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 236 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 2,493 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.05 to 0.45) · 6,081 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.06 to 0.44) · 6,217 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.57 (3.24 to 7.9) · 531 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 47 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.77 (0 to 18.62) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.1 (0.81 to 9.39) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 126 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.7 (0.11 to 1.28) · 5,664 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.821 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.665 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.6 · 164 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.5 · 586 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 49.7 · 108 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 38.9 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 115.2 · 661 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 21.4 · 720 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 282 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.1 to 16.8) · 126 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 42 cases | No different | Jan 2024 – Dec 2024 |
What patients said (451 patients answered, 11% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$18,869
Medicare paid this office $18,869 for 81 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $3,628 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,953 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,215 | $64 |
Who their Medicare patients are
81 Original Medicare patients in 2024. Average age 76 · Under 65 14% · 85 and older 21% · Women 47% · Also on Medicaid 28% · Health risk score 1.72. Above the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Stroke 75% · Coronary heart disease 53% · Diabetes 43% · Heart failure 41% · Chronic kidney disease 38% · Atrial fibrillation 36% · Depression 33% · COPD 28% · Cancer 26% · Dementia 26%.
The office billed $87,545, Medicare allowed $23,754 and paid $18,869; for 132 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 81 | 132 | 76 | 1.72 | $87,545 | $18,869 |
| 2023 | 47 | 53 | 76 | 1.53 | $13,891 | $6,144 |
| 2022 | 120 | 2,497 | 76 | 1.50 | $105,800 | $32,630 |
| 2021 | 160 | 3,545 | 74 | 1.66 | $194,673 | $58,890 |
| 2020 | 203 | 3,221 | 74 | 1.75 | $341,108 | $96,411 |
| 2019 | 219 | 925 | 76 | 1.74 | $365,556 | $104,290 |
| 2018 | 232 | 616 | 76 | 1.89 | $296,054 | $105,124 |
| 2017 | 91 | 280 | 75 | 1.67 | $96,415 | $38,557 |
| 2016 | 38 | 102 | 72 | 1.30 | $23,587 | $5,197 |
| 2015 | 361 | 6,489 | 73 | 1.43 | $805,781 | $253,368 |
| 2014 | 514 | 3,020 | 70 | 1.72 | $307,052 | $153,946 |
| 2013 | 563 | 1,099 | 70 | 1.97 | $227,663 | $120,411 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 17 | $1,296 | $76 |
| Short return visit (20+ min) | 16 | $826 | $52 |
2022: 5 services
| Critical care, first 30-74 minutes | 26 | $5,522 | $162 |
| Return visit (30+ min) | 20 | $2,031 | $85 |
| New patient visit (45+ min) | 15 | $1,813 | $121 |
| Short return visit (20+ min) | 28 | $1,723 | $62 |
| New patient visit (30+ min) | 20 | $1,722 | $86 |
2021: 7 services
| Critical care, first 30-74 minutes | 22 | $7,014 | $167 |
| Return visit (30+ min) | 47 | $4,414 | $87 |
| Short return visit (20+ min) | 27 | $1,972 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,805 | $100 |
| New patient visit (45+ min) | 13 | $1,701 | $131 |
| Long return visit (40+ min) | 11 | $1,697 | $141 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $194 | $10 |
2020: 13 services
| Critical care, first 30-74 minutes | 66 | $18,296 | $174 |
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 11 | $7,306 | $664 |
| Return visit (30+ min) | 52 | $4,445 | $79 |
| Insertion of tube into neck or brain artery for diagnosis or treatment with review by radiologist | 11 | $3,978 | $221 |
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 13 | $3,736 | $287 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $3,242 | $81 |
| Long return visit (40+ min) | 25 | $3,064 | $109 |
| New patient visit (60+ min) | 18 | $2,755 | $153 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,591 | $152 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,394 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,263 | $57 |
| Short return visit (20+ min) | 23 | $1,175 | $51 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 37 | $376 | $10 |
2019: 15 services
| Critical care, first 30-74 minutes | 75 | $19,460 | $172 |
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 29 | $19,419 | $670 |
| Insertion of stent and blood clot protection device in neck artery with review by radiologist | 12 | $9,342 | $779 |
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 16 | $6,327 | $372 |
| Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | 24 | $6,117 | $255 |
| Return visit (30+ min) | 64 | $4,708 | $69 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,430 | $158 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 19 | $3,389 | $178 |
| New patient visit (60+ min) | 22 | $2,788 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $2,170 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,932 | $107 |
| Long return visit (40+ min) | 16 | $1,773 | $104 |
| Insertion of tube into chest artery for diagnosis or treatment with review by radiologist | 12 | $1,648 | $137 |
| Short return visit (20+ min) | 11 | $580 | $53 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 56 | $556 | $10 |
2018: 14 services
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 30 | $19,842 | $661 |
| Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | 54 | $17,522 | $324 |
| Insertion of stent and blood clot protection device in neck artery with review by radiologist | 13 | $10,528 | $810 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 42 | $8,055 | $192 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $6,951 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $6,688 | $83 |
| Critical care, first 30-74 minutes | 29 | $6,427 | $174 |
| Long return visit (40+ min) | 43 | $5,060 | $110 |
| Return visit (30+ min) | 52 | $4,479 | $79 |
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 13 | $3,684 | $283 |
| New patient visit (60+ min) | 21 | $3,288 | $157 |
| Insertion of tube into chest artery for diagnosis or treatment with review by radiologist | 15 | $2,099 | $140 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 86 | $905 | $10 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $592 | $54 |
2017: 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $7,176 | $159 |
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 11 | $6,896 | $627 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $6,078 | $82 |
| Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | 14 | $3,997 | $286 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 14 | $2,938 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $852 | $57 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 30 | $292 | $10 |
2016: 2 services
| New patient visit (60+ min) | 11 | $1,446 | $131 |
| Telehealth originating site facility fee | 24 | $413 | $17 |
2015: 40 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 15 | $21,348 | $1,256 |
| New patient visit (45+ min) | 147 | $16,452 | $112 |
| Return visit (30+ min) | 124 | $11,842 | $80 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 51 | $11,746 | $178 |
| Nerve test | 46 | $10,941 | $233 |
| Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | 11 | $9,843 | $895 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 38 | $9,449 | $152 |
| Long return visit (40+ min) | 76 | $9,280 | $105 |
| New patient visit (60+ min) | 59 | $8,870 | $150 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 43 | $6,753 | $138 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 50 | $4,961 | $72 |
| Injections of substances into lower or sacral spine | 23 | $4,558 | $152 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 36 | $4,208 | $77 |
| Mri scan of brain before and after contrast | 12 | $3,207 | $267 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 68 | $2,408 | None |
| Review by radiologist of both arms or legs arteries image | 14 | $2,059 | $147 |
| Fluoroscopic guidance for spine or back muscle injection | 22 | $1,747 | $67 |
| Review by radiologist of pelvis artery image | 14 | $1,722 | $115 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 19 | $1,662 | $69 |
| Injection of trigger points, 3 or more muscles | 48 | $1,643 | $29 |
| Injection into tendon at attachment to bone or muscle | 35 | $1,557 | $26 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 12 | $1,440 | $85 |
| Review by radiologist of abdominal aorta image | 11 | $1,093 | $99 |
| Ultrasonic guidance for needle placement | 15 | $950 | $47 |
| Review by radiologist of additional artery image | 12 | $831 | $69 |
| Injection, methylprednisolone acetate, 40 mg | 93 | $712 | None |
| Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 19 | $696 | $2 |
| Aspiration and/or injection of fluid from large joint | 14 | $634 | $42 |
| Telehealth originating site facility fee | 26 | $544 | $19 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 26 | $319 | $0 |
| Blood test, thyroid stimulating hormone (tsh) | 12 | $269 | $22 |
| Cyanocobalamin (vitamin b-12) level, unsaturated binding capacity | 11 | $210 | $19 |
| Magnesium level | 23 | $205 | $9 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 22 | $188 | $9 |
| Insertion of needle into vein for collection of blood sample | 41 | $165 | $3 |
| Thyroxine (thyroid chemical), free | 13 | $156 | $12 |
| Blood test, basic group of blood chemicals (calcium, total) | 16 | $139 | $9 |
| Blood test, comprehensive group of blood chemicals | 13 | $118 | $9 |
| Phosphate level | 23 | $94 | $4 |
| Injection, ketorolac tromethamine, per 15 mg | 14 | $11 | None |
2014: 27 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 112 | $18,627 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 112 | $15,688 | $82 |
| New patient visit (45+ min) | 114 | $14,683 | $129 |
| Return visit (30+ min) | 85 | $7,503 | $77 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 28 | $7,273 | $177 |
| New patient visit (60+ min) | 42 | $6,465 | $154 |
| Long return visit (40+ min) | 50 | $6,340 | $109 |
| Nerve test | 23 | $5,986 | $239 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 18 | $4,826 | $138 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 24 | $3,658 | $135 |
| Ultrasonic guidance for needle placement | 45 | $3,574 | $58 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 27 | $3,557 | $70 |
| Short return visit (20+ min) | 55 | $3,056 | $53 |
| Critical care, first 30-74 minutes | 14 | $2,745 | $183 |
| Ultrasound of both sides of head and neck blood flow | 17 | $2,459 | $145 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 16 | $2,133 | $69 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 15 | $1,865 | $69 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $1,698 | $57 |
| Injections of substances into lower or sacral spine | 18 | $1,482 | $78 |
| Injection of trigger points, 3 or more muscles | 33 | $1,203 | $30 |
| Injection into tendon at attachment to bone or muscle | 29 | $1,167 | $25 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 34 | $994 | None |
| Aspiration and/or injection of fluid from large joint | 20 | $888 | $34 |
| Fluoroscopic guidance for spine or back muscle injection | 11 | $778 | $71 |
| Injection, methylprednisolone acetate, 40 mg | 55 | $504 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 25 | $25 | None |
| Injection, ketorolac tromethamine, per 15 mg | 17 | $9 | None |
2013: 12 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 240 | $41,177 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 223 | $28,529 | $82 |
| Critical care, first 30-74 minutes | 32 | $7,253 | $165 |
| Long return visit (40+ min) | 49 | $6,820 | $114 |
| Return visit (30+ min) | 62 | $6,024 | $84 |
| New patient visit (60+ min) | 33 | $5,392 | $163 |
| Ultrasound of both sides of head and neck blood flow | 30 | $4,452 | $148 |
| New patient visit (60+ min) | 25 | $3,330 | $133 |
| Short return visit (20+ min) | 34 | $2,068 | $59 |
| Long return visit (40+ min) | 19 | $1,877 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $1,860 | $58 |
| New patient visit (45+ min) | 12 | $1,530 | $128 |
Drugs they prescribed that Part D paid
$3,382
Pharmacies billed $3,382 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 51) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
45 generic and fewer than 11 brand-name prescriptions · $3,382 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Telmisartan | 14 | $164 | $12 |
| Atorvastatin | 11 | $68 | $6 |
Year by year
| 2024 | 51 | 14 | 0% (0) | None | $3,382 |
| 2023 | 96 | 32 | 0% (0) | 18% | $13,954 |
| 2022 | 274 | 57 | 0% (0) | 14% | $42,104 |
| 2021 | 369 | 73 | 0% (0) | 11% | $50,333 |
| 2020 | 351 | 74 | 0% (0) | 18% | $43,311 |
| 2019 | 229 | 67 | 0% (0) | None | $9,993 |
| 2018 | 129 | 43 | 0% (0) | None | $5,694 |
| 2017 | 63 | 25 | None | None | $3,250 |
| 2016 | 219 | 68 | None | 15% | $29,435 |
| 2015 | 751 | 188 | 3% (20) | 19% | $154,308 |
| 2014 | 1,413 | 253 | 15% (205) | None | $223,778 |
| 2013 | 490 | 119 | 10% (49) | None | $67,800 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Rosuvastatin | 27 | $435 | $16 |
| Mirtazapine | 11 | $104 | $9 |
2022: 11 drugs
| Nuedexta | 11 | $16,652 | $1,514 |
| Xarelto | 12 | $6,641 | $553 |
| Memantine | 30 | $3,531 | $118 |
| Levetiracetam | 16 | $967 | $60 |
| Mycophenolate Mofetil | 15 | $909 | $61 |
| Rosuvastatin | 24 | $623 | $26 |
| Atorvastatin | 32 | $520 | $16 |
| Telmisartan | 17 | $386 | $23 |
| Amlodipine Besylate | 11 | $251 | $23 |
| Donepezil | 22 | $210 | $10 |
| Mirtazapine | 13 | $179 | $14 |
2021: 11 drugs
| Xarelto | 31 | $25,820 | $833 |
| Memantine | 25 | $1,328 | $53 |
| Mycophenolate Mofetil | 17 | $1,006 | $59 |
| Levetiracetam | 24 | $802 | $33 |
| Atorvastatin | 54 | $642 | $12 |
| Rosuvastatin | 14 | $466 | $33 |
| Donepezil | 22 | $403 | $18 |
| Clopidogrel | 40 | $332 | $8 |
| Amlodipine Besylate | 33 | $204 | $6 |
| Mirtazapine | 13 | $87 | $7 |
| Lisinopril | 15 | $81 | $5 |
2020: 10 drugs
| Xarelto | 36 | $17,022 | $473 |
| Eliquis | 16 | $13,515 | $845 |
| Mirtazapine | 20 | $969 | $48 |
| Donepezil | 41 | $612 | $15 |
| Atorvastatin | 26 | $318 | $12 |
| Amlodipine Besylate | 23 | $291 | $13 |
| Clopidogrel | 23 | $237 | $10 |
| Losartan-Hydrochlorothiazide | 11 | $198 | $18 |
| Levetiracetam | 16 | $196 | $12 |
| Lisinopril | 31 | $167 | $5 |
2019: 5 drugs
| Clopidogrel | 69 | $730 | $11 |
| Atorvastatin | 18 | $348 | $19 |
| Donepezil | 21 | $270 | $13 |
| Ramipril | 16 | $201 | $13 |
| Amlodipine Besylate | 15 | $102 | $7 |
2018: 3 drugs
| Clopidogrel | 41 | $406 | $10 |
| Atorvastatin | 17 | $398 | $23 |
| Ramipril | 19 | $380 | $20 |
2017: 2 drugs
| Atorvastatin | 12 | $147 | $12 |
| Clopidogrel | 14 | $122 | $9 |
2016: 5 drugs
| Amitriptyline | 14 | $326 | $23 |
| Gabapentin | 14 | $310 | $22 |
| Clopidogrel | 21 | $254 | $12 |
| Atorvastatin | 26 | $251 | $10 |
| Donepezil | 13 | $138 | $11 |
2015: 20 drugs
| Copaxone | 12 | $60,598 | $5,050 |
| Lyrica | 19 | $13,012 | $685 |
| Namenda | 12 | $4,187 | $349 |
| Voltaren | 14 | $3,286 | $235 |
| Duloxetine | 21 | $3,177 | $151 |
| Gabapentin | 59 | $1,878 | $32 |
| Levetiracetam | 35 | $1,476 | $42 |
| Baclofen | 27 | $786 | $29 |
| Amitriptyline | 45 | $724 | $16 |
| Sumatriptan | 41 | $692 | $17 |
| Carbidopa-Levodopa | 21 | $644 | $31 |
| Donepezil | 29 | $505 | $17 |
| Topiramate | 35 | $496 | $14 |
| Pramipexole Dihydrochloride | 24 | $369 | $15 |
| Atorvastatin | 17 | $280 | $16 |
| Alendronate | 24 | $252 | $10 |
| Simvastatin | 21 | $186 | $9 |
| Clonidine | 14 | $186 | $13 |
| Clopidogrel | 14 | $161 | $12 |
| Quetiapine | 11 | $104 | $9 |
2014: 35 drugs
| Copaxone | 12 | $57,056 | $4,755 |
| Lyrica | 37 | $17,665 | $477 |
| Voltaren | 81 | $12,120 | $150 |
| Namenda | 33 | $11,567 | $351 |
| Vimpat | 11 | $8,236 | $749 |
| Lidocaine | 35 | $7,789 | $223 |
| Duloxetine | 26 | $6,519 | $251 |
| Xarelto | 21 | $5,279 | $251 |
| Gabapentin | 91 | $3,565 | $39 |
| Divalproex Sodium Er | 11 | $3,059 | $278 |
| Oxycodone | 63 | $2,789 | $44 |
| Sumatriptan | 24 | $2,388 | $99 |
| Hydrocodone-Acetaminophen | 98 | $2,386 | $24 |
| Indomethacin | 30 | $1,962 | $65 |
| Levetiracetam | 40 | $1,718 | $43 |
| Carisoprodol | 39 | $1,594 | $41 |
| Donepezil | 27 | $1,176 | $44 |
| Carbamazepine | 13 | $1,071 | $82 |
| Tizanidine | 12 | $883 | $74 |
| Amitriptyline | 69 | $779 | $11 |
| Pramipexole Dihydrochloride | 37 | $623 | $17 |
| Lamotrigine | 29 | $584 | $20 |
| Atorvastatin | 21 | $563 | $27 |
| Topiramate | 23 | $538 | $23 |
| Baclofen | 32 | $467 | $15 |
| Mirtazapine | 13 | $319 | $25 |
| Ropinirole | 11 | $304 | $28 |
| Zonisamide | 13 | $297 | $23 |
| Alprazolam | 34 | $211 | $6 |
| Simvastatin | 15 | $160 | $11 |
| Alendronate | 11 | $128 | $12 |
| Clonazepam | 23 | $103 | $4 |
| Diazepam | 18 | $101 | $6 |
| Meloxicam | 16 | $76 | $5 |
| Amlodipine Besylate | 17 | $75 | $4 |
2013: 14 drugs
| Vimpat | 11 | $6,157 | $560 |
| Lyrica | 12 | $3,204 | $267 |
| Namenda | 13 | $2,123 | $163 |
| Voltaren | 11 | $1,902 | $173 |
| Levetiracetam | 40 | $1,492 | $37 |
| Gabapentin | 22 | $642 | $29 |
| Clopidogrel | 17 | $528 | $31 |
| Topiramate | 20 | $505 | $25 |
| Primidone | 11 | $434 | $39 |
| Hydrocodone-Acetaminophen | 17 | $419 | $25 |
| Lamotrigine | 26 | $291 | $11 |
| Pramipexole Dihydrochloride | 13 | $253 | $19 |
| Amitriptyline | 36 | $145 | $4 |
| Prednisone | 12 | $33 | $3 |
Money from drug and device companies
$37 in 2024
| 2024 | 1 | 1 | None | $37 |
| 2023 | 2 | 2 | None | $80 |
| 2022 | 4 | 11 | None | $1,585 |
| 2021 | 1 | 2 | None | $243 |
| 2020 | 1 | 1 | None | $62 |
| 2019 | 5 | 37 | None | $4,119 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Qapel Medical | None | $37 | 1 payment
|
See the published payment
| Qapel Medical | Meals · 2024-04-18 | None | $37 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $80
| Penumbra | Penumbra System | $66 | 1 payment
|
| MicroVention | Stent | $14 | 1 payment
|
2022: $1,585
| Siemens Medical Solutions USA | Artis Icono Biplane | $1,205 | 6 payments
|
| Philips Electronics North America | (8306) Azurion 7 B20 | $294 | 3 payments
|
| Penumbra | Penumbra System | $58 | 1 payment
|
| Abbvie | Botox | $30 | 1 payment
|
2021: $243
| Penumbra | Penumbra Coil 400 | $243 | 2 payments
|
2020: $62
| Penumbra | Smart | $62 | 1 payment
|
2019: $4,119
| Penumbra | Penumbra System | $2,535 | 14 payments
|
| Medtronic USA | Pipeline | $1,214 | 18 payments
|
| Stryker | Atlas | $207 | 3 payments
|
| Alexion Pharmaceuticals | Soliris | $98 | 1 payment
|
| MicroVention | Web | $65 | 1 payment
|
Professional record
- NPI
- 1366658627
- Licence
- OR MD192398
- Group
- Neuranimus P C · Physician Affiliate Group of New York PC
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2084V0102X (2084V0102X); Federal specialty code 2085R0204X (2085R0204X)
- Mailing address
- 1553 Devonshire Pl, Medford, OR, 97504
- NPI first listed
- 2007-05-15
- NPI last updated
- 2026-01-20
- NPI record certified
- 2026-01-20
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.